In the posting last week I suggested that resistance to antibiotics should be added to the threats facing humanity. This has been confirmed by the Final Report to government from the Review on Antimicrobial Resistance (AMR) published today. In the preface to this report, Lord O’Neill, now a government minister, accepts that routine surgeries and minor infections will become life-threatening once again and that the hard won victories against infectious diseases of the last fifty [surely sixty plus] years will be jeopardized. Unless action is taken, the report concludes, the number of deaths each year from AMR could balloon to 10 million, at a cumulative cost to global economic output of $100 trillion. On this basis, by 2050, the death toll could be a staggering one person every three seconds and each person in the world today will be more than $10,000 per annum worse off – quite a problem when the world average income is currently less than $18,000 per annum – but such distributional matters tend not to concern Tory ministers.
Some of the report’s recommendations are obvious, including restricting doctors from prescribing antibiotics until they have confirmed with tests that they are actually required. Others are conspicuous by their absence and reflect the prejudices of the government of which Lord O’Neill is a member. These include the need to block TTIP so that US factory farming methods dependent on intensive antibiotic use are not forced on us when this agreement with the EU is signed. Leaving the EU is the best, possibly only, way of stopping TTIP – what a shame that the official Brexit Campaign, dominated as it is by right wing Tories, is so reluctant to point this out.
The report concludes that remedial action can be financed from existing NHS budgets. That will generate a huge sigh of relief from a government unwilling to provide an adequate level of funding for even current services. It depends, however, on the assumption that the drug companies can be made to pay. The key recommendation is a new settlement with Big Pharma, a so-called ‘pay and play’ requirement: pay for the investment in new antibiotics and inoculation in exchange for continuing their privileged position as monopoloy suppliers to governments. Given Big Pharma’s record of dodging taxes and ripping off governments, this has all the prospects of a snow ball in hell. The knee jerk reaction from the trade body the Association of the British Pharmaceutical Industry was, as would be expected, immediate rejection.
Big Pharma is the epitome of capitalism and the illusion that if we give the rich and powerful everything they want, the welfare of everyone else will be enhanced. The truth is that, as with global warming, international, profit driven enterprises cannot be trusted with the fate of humanity. They will always put the interests of the elites who own them or feed off them as managers first. They must be cut down to size, stripped of their monopolies and, in the case of Big Pharma, replaced with democratically controlled research institutes. If the impoverished Cubans can do it, so can we!